Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis

被引：2
|
作者：
Boyd, MA [1 ]
Burger, DM
Phanuphak, P
Cooper, DA
机构：
[1] Flinders Univ S Australia, Dept Microbiol & Infect Dis, Bedford Pk, SA 5042, Australia
[2] Radboud Univ, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[3] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand
[4] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
来源：
AIDS | 2006年 / 20卷 / 07期
关键词：
D O I：
10.1097/01.aids.0000222090.52035.b2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1083 / 1085
页数：3
相关论文
共 50 条
  • [1] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Dailly, Eric
    Tribut, Olivier
    Tattevin, Pierre
    Arvieux, Cedric
    Perre, Philippe
    Raffi, Francois
    Jolliet, Pascale
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 523 - 526
  • [2] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Eric Dailly
    Olivier Tribut
    Pierre Tattevin
    Cédric Arvieux
    Philippe Perré
    François Raffi
    Pascale Jolliet
    [J]. European Journal of Clinical Pharmacology, 2006, 62 : 523 - 526
  • [3] Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
    Nishijima, Takeshi
    Hamada, Yohei
    Watanabe, Koji
    Komatsu, Hirokazu
    Kinai, Ei
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    [J]. PLOS ONE, 2013, 8 (10):
  • [4] Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children
    Violari, Avy
    Lindsey, Jane C.
    Hughes, Michael D.
    Mujuru, Hilda A.
    Barlow-Mosha, Linda
    Kamthunzi, Portia
    Chi, Benjamin H.
    Cotton, Mark F.
    Moultrie, Harry
    Khadse, Sandhya
    Schimana, Werner
    Bobat, Raziya
    Purdue, Lynette
    Eshleman, Susan H.
    Abrams, Elaine J.
    Millar, Linda
    Petzold, Elizabeth
    Mofenson, Lynne M.
    Jean-Philippe, Patrick
    Palumbo, Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (25): : 2380 - 2389
  • [5] Impact of nevirapine or efavirenz co-administration on ritonavir-boosted amprenavir pharmacokinetics in HIV-infected patients
    Dailly, Eric
    Raffi, Francois
    Biron, Charlotte
    Allavena, C.
    Jolliet, P.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 (01) : 101 - 104
  • [6] Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
    Zeldin, RK
    Petruschke, RA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 4 - 9
  • [7] Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients
    Dailly, Eric
    Allavena, Clotilde
    Bouquie, Regis
    Deslandes, Guillaume
    Raffi, Francois
    Jolliet, Pascale
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 42 - 46
  • [8] Dual therapy with dolutegravir plus ritonavir-boosted or unboosted atazanavir as a maintenance treatment in highly experienced HIV-infected patients
    Faycal, A.
    Abdi, B.
    Peytavin, G.
    Tebano, G.
    Schneider, L.
    Seang, S.
    Simon, A.
    Tubiana, R.
    Valantin, M.
    Marcelin, A.
    Katlama, C.
    Palich, R.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [9] Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David J.
    Khoo, Saye H.
    Pozniak, Anton L.
    Mugyenyi, Peter
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David M.
    Aarons, Leon J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1344 - 1355
  • [10] Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected and healthy individuals
    Dickinson, Laura
    Aarons, Leon
    Back, David
    Khoo, Saye
    Else, Laura
    Waters, Laura
    Pozniak, Anton
    Boffito, Marta
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 304 - 305
12345